PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18

被引:12
|
作者
Saidu, Nathaniel Edward Bennett [1 ]
Filic, Vedrana [2 ]
Thomas, Miranda [3 ]
Sarabia-Vega, Vanessa [3 ]
Dukic, Anamaria [1 ]
Miljkovic, Frane [1 ,4 ]
Banks, Lawrence [3 ]
Tomaic, Vjekoslav [1 ]
机构
[1] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia
[2] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia
[3] Int Ctr Genet Engn & Biotechnol, Trieste, Italy
[4] Vienna Bioctr, Vienna, Austria
关键词
HPV; E6; oncoprotein; cervical cancer; NHERF-2; p27; cyclin D1; cell proliferation; TYPE-16; E6; PROTEIN; HIGH-RISK; BINDING MOTIF; CERVICAL-CANCER; LIFE-CYCLE; CELL-CYCLE; E7; ONCOPROTEINS; RECEPTOR; COMPLEX;
D O I
10.1128/JVI.00663-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cancer-causing human papillomavirus (HPV) E6 oncoproteins have a class I PDZ-binding motif (PBM) on their C termini, which play critical roles that are related to the HPV life cycle and HPV-induced malignancies. E6 oncoproteins use these PBMs to interact with, to target for proteasome-mediated degradation, a plethora of cellular substrates that contain PDZ domains and that are involved in the regulation of various cellular pathways. In this study, we show that both HPV-16 and HPV-18 E6 oncoproteins can interact with Na+/H+ exchange regulatory factor 2 (NHERF-2), a PDZ domain-containing protein, which among other cellular functions also behaves as a tumor suppressor regulating endothelial proliferation. The interaction between the E6 oncoproteins and NHERF-2 is PBM dependent and results in proteasome-mediated degradation of NHERF-2. We further confirmed this effect in cells derived from HPV-16- and HPV-18-positive cervical tumors, where we show that NHERF-2 protein turnover is increased in the presence of E6. Finally, our data indicate that E6-mediated NHERF-2 degradation results in p27 downregulation and cyclin D1 upregulation, leading to accelerated cellular proliferation. To our knowledge, this is the first report to demonstrate that E6 oncoproteins can stimulate cell proliferation by indirectly regulating p27 through targeting a PDZ domain-containing protein. IMPORTANCE This study links HPV-16 and HPV-18 E6 oncoproteins to the modulation of cellular proliferation. The PDZ domain-containing protein NHERF-2 is a tumor suppressor that has been shown to regulate endothelial proliferation; here, we demonstrate that NHERF-2 is targeted by HPV E6 for proteasome-mediated degradation. Interestingly, this indirectly affects p27, cyclin D1, and CDK4 protein levels and, consequently, affects cell proliferation. Hence, this study provides information that will improve our understanding of the molecular basis for HPV E6 function, and it also highlights the importance of the PDZ domain-containing protein NHERF-2 and its tumor-suppressive role in regulating cell proliferation.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18)
    Frati, E.
    Bianchi, S.
    Colzani, D.
    Zappa, A.
    Orlando, G.
    Tanzi, E.
    [J]. INFECTION GENETICS AND EVOLUTION, 2011, 11 (08) : 2119 - 2124
  • [2] PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6
    Thomas, Miranda
    Banks, Lawrence
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (02) : 1439 - 1444
  • [3] Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women
    Feder, Molly A.
    Kulasingam, Shalini L.
    Kiviat, Nancy B.
    Mao, Constance
    Nelson, Erik J.
    Winer, Rachel L.
    Whitham, Hilary K.
    Lin, John
    Hawes, Stephen E.
    [J]. JOURNAL OF WOMENS HEALTH, 2019, 28 (10) : 1428 - 1435
  • [4] A Systematic Analysis of Human Papillomavirus (HPV) E6 PDZ Substrates Identifies MAGI-1 as a Major Target of HPV Type 16 (HPV-16) and HPV-18 Whose Loss Accompanies Disruption of Tight Junctions
    Kranjec, Christian
    Banks, Lawrence
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (04) : 1757 - 1764
  • [5] Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia
    Hillemanns, P
    Wang, XL
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 276 - 282
  • [6] ABSENCE OF HPV-16 AND HPV-18 DNA IN BREAST-CANCER
    WREDE, D
    LUQMANI, YA
    COOMBES, RC
    VOUSDEN, KH
    [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (06) : 891 - 894
  • [7] The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children
    Marais, Dianne J.
    Sampson, Candice C.
    Urban, Margaret I.
    Sitas, Freddy
    Wiliamson, Anna-Lise
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) : 1370 - 1374
  • [8] Acquisition and Persistence of Human Papillomavirus 16 (HPV-16) and HPV-18 Among Men With High-HPV Viral Load Infections in a Circumcision Trial in Kisumu, Kenya
    Senkomago, Virginia
    Backes, Danielle M.
    Hudgens, Michael G.
    Poole, Charles
    Agot, Kawango
    Moses, Stephen
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Hesselink, Albertus T.
    Schlecht, Nicolas F.
    Bailey, Robert C.
    Smith, Jennifer S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (05): : 811 - 820
  • [9] Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity
    Thatte, Jayashree
    Banks, Lawrence
    [J]. JOURNAL OF VIROLOGY, 2017, 91 (22)
  • [10] Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old
    Ang, Joella Xiaohong
    Lee, Wai Yen
    Tay, Sun Kuie
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (05) : 259 - 267